☰

Chaitra Gopalappa, Ph.D. - Publications

Affiliations: 
2010 University of South Florida, Tampa, FL, United States 
Area:
Industrial Engineering, Bioinformatics Biology, Public Health, Biomedical Engineering
Tree Info Similar researchers PubMed Report error

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Tatapudi H, Gopalappa C. Evaluating the sensitivity of jurisdictional heterogeneity and jurisdictional mixing in national level HIV prevention analyses: context of the U.S. ending the HIV epidemic plan. Bmc Medical Research Methodology. 22: 304. PMID 36435750 DOI: 10.1186/s12874-022-01756-w  0.353
2021 Khatami SN, Gopalappa C. A reinforcement learning model to inform optimal decision paths for HIV elimination. Mathematical Biosciences and Engineering : Mbe. 18: 7666-7684. PMID 34814269 DOI: 10.3934/mbe.2021380  0.308
2020 Bansal S, Deshpande V, Zhao X, Lauer JA, Meheus F, Ilbawi A, Gopalappa C. Analysis of Mammography Screening Schedules under Varying Resource Constraints for Planning Breast Cancer Control Programs in Low- and Middle-Income Countries: A Mathematical Study. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X20910724. PMID 32160823 DOI: 10.1177/0272989X20910724  0.344
2018 Ralaidovy AH, Gopalappa C, Ilbawi A, Pretorius C, Lauer JA. Cost-effective interventions for breast cancer, cervical cancer, and colorectal cancer: new results from WHO-CHOICE. Cost Effectiveness and Resource Allocation : C/E. 16: 38. PMID 30450014 DOI: 10.1186/S12962-018-0157-0  0.333
2018 Gopalappa C, Guo J, Meckoni P, Munkhbat B, Pretorius C, Lauer J, Ilbawi A, Bertram M. A Two-Step Markov Processes Approach for Parameterization of Cancer State-Transition Models for Low- and Middle-Income Countries. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X18759482. PMID 29577814 DOI: 10.1177/0272989X18759482  0.379
2017 Gopalappa C, Sansom SL, Farnham PG, Chen YH. Combinations of interventions to achieve a national HIV incidence reduction goal: insights from the agent-based PATH 2.0 model. Aids (London, England). PMID 29028657 DOI: 10.1097/Qad.0000000000001653  0.432
2016 Gopalappa C, Farnham PG, Chen YH, Sansom SL. Progression and Transmission of HIV/AIDS (PATH 2.0): A New Agent-Based Model to Estimate HIV Transmissions in the United States. Medical Decision Making : An International Journal of the Society For Medical Decision Making. PMID 27646567 DOI: 10.1177/0272989X16668509  0.422
2015 Eaton JW, Bacaër N, Bershteyn A, Cambiano V, Cori A, Dorrington RE, Fraser C, Gopalappa C, Hontelez JA, Johnson LF, Klein DJ, Phillips AN, Pretorius C, Stover J, Rehle TM, et al. Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy era. The Lancet. Global Health. 3: e598-608. PMID 26385301 DOI: 10.1016/S2214-109X(15)00080-7  0.423
2014 Stover J, Andreev K, Slaymaker E, Gopalappa C, Sabin K, Velasquez C, Nakiyingi-Miiro J, Crampin A, Lutalo T, Herbst K, Gregson S, Urassa M. Updates to the spectrum model to estimate key HIV indicators for adults and children. Aids (London, England). 28: S427-34. PMID 25406748 DOI: 10.1097/Qad.0000000000000483  0.445
2014 Stover J, Hallett TB, Wu Z, Warren M, Gopalappa C, Pretorius C, Ghys PD, Montaner J, Schwartländer B. How can we get close to zero? The potential contribution of biomedical prevention and the investment framework towards an effective response to HIV. Plos One. 9: e111956. PMID 25372770 DOI: 10.1371/Journal.Pone.0111956  0.444
2014 Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, ... ... Gopalappa C, et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. The Lancet. Global Health. 2: e23-34. PMID 25104632 DOI: 10.1016/S2214-109X(13)70172-4  0.367
2014 Stover J, Gopalappa C, Mahy M, Doherty MC, Easterbrook PJ, Weiler G, Ghys PD. The impact and cost of the 2013 WHO recommendations on eligibility for antiretroviral therapy. Aids (London, England). 28: S225-30. PMID 24849482 DOI: 10.1097/Qad.0000000000000235  0.362
2014 Gopalappa C, Stover J, Shaffer N, Mahy M. The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV. Aids (London, England). 28: S5-14. PMID 24468947 DOI: 10.1097/Qad.0000000000000083  0.404
2014 Pretorius C, Menzies NA, Chindelevitch L, Cohen T, Cori A, Eaton JW, Fraser C, Gopalappa C, Hallett TB, Salomon JA, Stover J, White RG, Dodd PJ. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. Aids (London, England). 28: S25-34. PMID 24468944 DOI: 10.1097/Qad.0000000000000085  0.41
2013 Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, ... ... Gopalappa C, et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. The Lancet. Global Health. 2: 23-34. PMID 25083415 DOI: 10.1016/S2214-109X(13)70172-4  0.331
2013 Farnham PG, Holtgrave DR, Gopalappa C, Hutchinson AB, Sansom SL. Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era. Journal of Acquired Immune Deficiency Syndromes (1999). 64: e15-8. PMID 24047975 DOI: 10.1097/Qai.0B013E3182A5C8D4  0.402
2013 Farnham PG, Gopalappa C, Sansom SL, Hutchinson AB, Brooks JT, Weidle PJ, Marconi VC, Rimland D. Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care. Journal of Acquired Immune Deficiency Syndromes (1999). 64: 183-9. PMID 23615000 DOI: 10.1097/Qai.0B013E3182973966  0.417
2012 Gopalappa C, Farnham PG, Hutchinson AB, Sansom SL. Cost effectiveness of the National HIV/AIDS Strategy goal of increasing linkage to care for HIV-infected persons. Journal of Acquired Immune Deficiency Syndromes (1999). 61: 99-105. PMID 22580563 DOI: 10.1097/Qai.0B013E31825Bd862  0.454
2011 Gopalappa C, Aydogan-Cremaschi S, Das TK, Orcun S. Probability model for estimating colorectal polyp progression rates. Health Care Management Science. 14: 1-21. PMID 20922484 DOI: 10.1007/S10729-010-9138-3  0.451
2009 Gopalappa C, Das TK, Enkemann S, Eschrich S. Removal of hybridization and scanning noise from microarrays. Ieee Transactions On Nanobioscience. 8: 210-8. PMID 20051337 DOI: 10.1109/Tnb.2009.2029100  0.407
Show low-probability matches.